- Isoliquiritigenin
-
- $100.00 / 50kg
-
2026-02-06
- CAS:961-29-5
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 5000Ton
- Isoliquiritigenin
-
- $46.00 / 1mL
-
2026-02-02
- CAS:961-29-5
- Min. Order:
- Purity: 99.21%
- Supply Ability: 10g
|
| | Isoliquiritigenin Basic information |
| Product Name: | Isoliquiritigenin | | Synonyms: | gu17;Isqliquiritigenin;ISOLIQUIRTEGENIN (2',4,4'-TRIHYDROXYCHAL;ISOLIQUIRITIGENIN(P);ISOLIQUIRITIGENIN(RG);(E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one, 4,2μ,4μ-Trihydroxychalcone;Isoliquiritigenin，4,2',4'-Trihydroxychalcone;(E)-2',4,4'-Trihydroxychalcone | | CAS: | 961-29-5 | | MF: | C15H12O4 | | MW: | 256.25 | | EINECS: | 607-884-2 | | Product Categories: | The group of Liquorice;sy;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Chalcones;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;Inhibitors | | Mol File: | 961-29-5.mol |  |
| | Isoliquiritigenin Chemical Properties |
| Melting point | 206-210°C | | Boiling point | 504.0±42.0 °C(Predicted) | | density | 1.384±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | H2O: <0.1 mg/mL | | pka | 7.50±0.35(Predicted) | | form | powder | | color | yellow to orange | | Water Solubility | H2O: <0.1mg/mL
methanol: 10mg/mL
DMSO: 20mg/mL | | Sensitive | Light Sensitive & Hygroscopic | | BRN | 1914296 | | Cosmetics Ingredients Functions | SKIN CONDITIONING - EMOLLIENT | | InChI | InChI=1S/C15H12O4/c16-11-4-1-10(2-5-11)3-8-14(18)13-7-6-12(17)9-15(13)19/h1-9,16-17,19H/b8-3+ | | InChIKey | DXDRHHKMWQZJHT-FPYGCLRLSA-N | | SMILES | C(C1=CC=C(O)C=C1O)(=O)/C=C/C1=CC=C(O)C=C1 | | LogP | 3.110 (est) | | CAS DataBase Reference | 961-29-5(CAS DataBase Reference) |
| Risk Statements | 36/37/38 | | Safety Statements | 26-37 | | WGK Germany | 3 | | RTECS | FL7080000 | | HS Code | 29145090 | | Storage Class | 11 - Combustible Solids |
| | Isoliquiritigenin Usage And Synthesis |
| Chemical Properties | Yellow solid | | Uses | aldose reductase inhibitor, antineoplastic, antiinflammatory | | Uses | Isoliquiritigenin (ISL) is a flavonoid found in licorice root and several other plants that displays antioxidant, anti-inflammatory, and antitumor activities as well as hepatoprotection against steatosis-induced oxidative stress. ISL induces quinone reductase-1, a phase II enzyme that deactivates radicals and electrophiles, with a concentration required to double activity (CD) value of 1.8 μM in murine hepatoma cells. | | Definition | ChEBI: Isoliquiritigenin is a member of the class of chalcones that is trans-chalcone hydroxylated at C-2', -4 and -4'. It has a role as an EC 1.14.18.1 (tyrosinase) inhibitor, a biological pigment, a NMDA receptor antagonist, a GABA modulator, a metabolite, an antineoplastic agent and a geroprotector. It is functionally related to a trans-chalcone. It is a conjugate acid of an isoliquiritigenin(1-). | | General Description | Isoliquiritigenin is an aromatic ketone and belongs to the chalcone group of compound. It is derived from licorice and is a component in medicine and food. | | Biochem/physiol Actions | Isoliquiritigenin is a soluble guanylyl cyclase activator and possesses antitumor activity. It also possesses antioxidant, antiplatelet and estrogenic properties. | | Anticancer Research | It is extracted from Dipteryx odorata seeds, found to be active in induction of quininereductase, and thus prevents chemical carcinogenesis. In a dose- and time-dependentmanner, it significantly inhibits the proliferation of prostate cancer cells,and this isoliquiritigenin-induced cell cycle arrest and antiproliferative effects maybe manifested by growth arrest- and DNA damage-inducible gene 153 (GADD153).It induces apoptosis in prostate cancer cells through mitochondrial apoptosispathway in which mitochondrial membrane potential is disrupted, cytochrome-cand Smac/Diablo are released, and caspase-9 is activated. It is reported to enhancethe expression of universal inhibitor of cyclin-dependent kinases, p21CIP1/WAF1, in adose- and time-dependent manner in A549 human lung cancer cells (Kanazawaet al. 2003; Ii et al. 2004; Balunas and Kinghorn 2005; Jung et al. 2006). | | storage | +4°C |
| | Isoliquiritigenin Preparation Products And Raw materials |
|